| 1 |
35068171 | The Correlation Between MDR1 Gene Polymorphism and Clopidogrel Resistance in People of the Hui and Han Nationalities. | 2022 Jan-Dec |
4 |
| 2 |
33033370 | The need of a multicomponent guiding approach to personalize clopidogrel treatment. | 2021 Apr |
2 |
| 3 |
33137324 | P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a. | 2021 Jan |
2 |
| 4 |
33270185 | Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention. | 2021 Apr |
2 |
| 5 |
33658839 | A Study on the Correlation Between MDR1 Polymorphism and Clopidogrel Resistance in Hui Patients Treated with Percutaneous Coronary Intervention. | 2021 |
2 |
| 6 |
33817306 | ABCB1 polymorphism in clopidogrel-treated Montenegrin patients. | 2021 |
1 |
| 7 |
34164723 | The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention. | 2021 Nov |
2 |
| 8 |
32702814 | CYP2C19, PON1, and ABCB1 gene polymorphisms in Han and Uygur populations with coronary artery disease in Northwestern Xinjiang, China, From 2014 Through 2019. | 2020 Jul 17 |
2 |
| 9 |
32862511 | Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease. | 2020 Dec |
2 |
| 10 |
32904459 | Increased Risk of Clopidogrel-Induced Gastric Mucosal Erosion in Elderly Chinese Men Harboring the ABCB1 3435T Allele. | 2020 |
5 |
| 11 |
33040624 | Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis. | 2020 Dec |
3 |
| 12 |
33224237 | Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention. | 2020 Spring |
3 |
| 13 |
33232268 | A SNP involved in alternative splicing of ABCB1 is associated with clopidogrel resistance in coronary heart disease in Chinese population. | 2020 Nov 20 |
1 |
| 14 |
30520344 | Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. | 2019 Jan |
1 |
| 15 |
30742211 | Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. | 2019 May 1 |
8 |
| 16 |
30916611 | Comparison between MassARRAY and pyrosequencing for CYP2C19 and ABCB1 gene variants of clopidogrel efficiency genotyping. | 2019 Dec |
1 |
| 17 |
31128980 | Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention. | 2019 Jun |
1 |
| 18 |
31184624 | [Genetic and non-genetic factors of laboratory resistance to clopidogrel in patients with ischemic stroke]. | 2019 |
1 |
| 19 |
31778598 | Distribution of polymorphisms in the CYP2C19 and ABCB1 genes among patients with acute coronary syndrome in Lower Silesian population. | 2019 Dec |
1 |
| 20 |
29350207 | Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients. | 2018 Feb |
3 |
| 21 |
29397568 | CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment. | 2018 Jun |
2 |
| 22 |
29424732 | Comment on "Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients". | 2018 Feb |
2 |
| 23 |
29777510 | Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. | 2018 Oct |
1 |
| 24 |
29936693 | Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel. | 2018 Jul |
3 |
| 25 |
30422888 | Investigating the Effect of Demographics, Clinical Characteristics, and Polymorphism of MDR-1, CYP1A2, CYP3A4, and CYP3A5 on Clopidogrel Resistance. | 2018 Dec |
1 |
| 26 |
28358842 | The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population. | 2017 |
2 |
| 27 |
28378058 | Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease. | 2017 Jul |
4 |
| 28 |
25850030 | A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study. | 2016 Feb |
1 |
| 29 |
26695516 | P-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration. | 2016 |
3 |
| 30 |
26699760 | Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East Asians. | 2016 Aug |
1 |
| 31 |
27112608 | [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome]. | 2016 Apr 24 |
3 |
| 32 |
27464309 | Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty. | 2016 Aug |
2 |
| 33 |
27756942 | Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults. | 2016 Jul-Aug |
2 |
| 34 |
29442035 | Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein. | 2016 Aug 1 |
3 |
| 35 |
25430046 | Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites. | 2015 Apr |
1 |
| 36 |
25452814 | Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism. | 2015 Jan |
1 |
| 37 |
25476742 | Clopidogrel use in end-stage kidney disease. | 2015 May-Jun |
3 |
| 38 |
25542807 | Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome. | 2015 Mar 10 |
4 |
| 39 |
25997249 | ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients. | 2015 Feb |
10 |
| 40 |
26362473 | C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention. | 2015 Nov |
5 |
| 41 |
24857912 | Development of a multiplex and cost-effective genotype test toward more personalized medicine for the antiplatelet drug clopidogrel. | 2014 May 5 |
1 |
| 42 |
25217066 | Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction. | 2014 Nov |
3 |
| 43 |
25606414 | ABCB1 C3435T and CYP2C19*2 polymorphisms in a Palestinian and Turkish population: A pharmacogenetic perspective to clopidogrel. | 2014 Dec |
2 |
| 44 |
23150151 | Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention. | 2013 May |
4 |
| 45 |
23333143 | Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function. | 2013 Feb 26 |
2 |
| 46 |
23364775 | Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes. | 2013 Apr |
2 |
| 47 |
23647895 | Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: effects on clopidogrel response. | 2013 Mar-Apr |
2 |
| 48 |
24088005 | [Informativeness of genetic factors for optimization of personalized therapy with clopidogrel]. | 2013 |
1 |
| 49 |
24378836 | Genetic and nongenetic factors influencing the response to clopidogrel. | 2013 Dec |
2 |
| 50 |
21358751 | Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness. | 2012 Aug |
1 |